SWTX — SpringWorks Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $2.79bn
- $2.36bn
- $5.45m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 328 | 508 | 374 | 592 | 479 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | — | 5.93 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 331 | 513 | 383 | 600 | 501 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.795 | 3.02 | 4.2 | 18.3 | 24.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 335 | 576 | 452 | 630 | 726 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12 | 17.6 | 30 | 51 | 78.2 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 12.8 | 19.1 | 30.1 | 72 | 99.6 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 322 | 557 | 422 | 558 | 626 |
Total Liabilities & Shareholders' Equity | 335 | 576 | 452 | 630 | 726 |
Total Common Shares Outstanding |